Clinical Trials Sponsored by Institut de cancérologie Strasbourg Europe

Total 457 results

Institut Cancerologie de l'Ouest

Completed

Medico-economic Evaluation Comparing Intensity-Modulated Radiation Therapy (IMRT) Performed by Helical Tomotherapy and Dynamic Arc Therapy in Prostate, Cervical and Anal Canal Cancers (RCMI PELVIS)

Cervical Cancer | Prostate Cancer | Anal Canal Cancers

France
Institut Cancerologie de l'Ouest

Completed

Study of 68Ga-HBED-PSMA PET/CT and Conventional Imaging in Occult Biological Relapse Prostate Cancer (PSMA REBIOLOC)

Prostate Cancer Recurrent

France
Institut Cancerologie de l'Ouest

Completed

Interest of Reticulocyte Haemoglobin Content (RET-he) in Management of Functional Anemia for Patient With Solid Tumor (RET-HE)

Solid Tumor, Adult | Anemia Deficiency

France
Institut Cancerologie de l'Ouest

Terminated

Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma Relapse (TOMMY)

Multiple Myeloma in Relapse

France
Institut Cancerologie de l'Ouest

Terminated

Pre-emptive Cycline Treatment on Cetuximab Induced Skin Toxicity in Colorectal Cancer (SKINUX)

Colorectal Cancer Metastatic | Skin Toxicity

France
Institut Cancerologie de l'Ouest

Completed

Molecular Biology Analysis for Para-aortic Nodes in the Ultra-staging of Advanced Cervical Cancers (GYNOSNA)

Advanced Cervical Cancer

France
Institut Cancerologie de l'Ouest

Completed

RSHF in Colorectal Cancer (RS CAMPTO)

Metastatic Colorectal Cancer

France
Institut Cancerologie de l'Ouest

Active, not recruiting

Medico Economic Study, Comparing Intrabeam® on Surgical Resection Bed to Conventional Surgery + EBRT, in Breast Cancer (RIOP-SEIN)

Menopausal Patients | Low-risk Breast Cancer

France
Institut de Cancérologie de la Loire

Completed

Therapeutic Education Intervention in Breast Cancer: PEPs Hormonotherapy (PEPs HORMONO)

Breast Cancer

France
Institut de Cancérologie de la Loire

Completed

Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells (VIRAUTO6)

Hematologic Diseases

France
Institut de Cancérologie de la Loire

Completed

Risk Factors for Thromboembolic and Infectious Complications Related to Percutaneous Central Venous Catheters in Cancer - Prospective Multicenter Study (ONCOCIP)

Cancer

France
Institut de Cancérologie de la Loire

Completed

Screening for Social Weaknesses and Coordination Course of Cancer Patients (DEFCOCANCERO)

Cancer

France
Institut de Cancérologie de la Loire

Completed

Feasibility Study of an Intervention Therapeutic Education for Patients Treated With Androgen Deprivation (Nutriprophy)

Prostate Cancer

France
Institut Cancerologie de l'Ouest

Not yet recruiting

Rurality Adapted Physical Activity Sport Health (RAPASS)

Metastatic Cancer | Brain Tumour

France
Institut Cancerologie de l'Ouest

Not yet recruiting

Assessment and Prevention of Caregiver Burden in Oncology (PREPAC-01)

Caregiver Burden | Oncology

France
Institut Cancerologie de l'Ouest

Recruiting

Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy (TRAILOCLORI01)

Metastatic Non Small Cell Lung Cancer | Locally Advanced Non Small Cell Lung Cancer

France
Institut Cancerologie de l'Ouest

Recruiting

Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin (REPAIR)

Prostate Cancer

France
Institut Cancerologie de l'Ouest

Recruiting

Impact of the Coordinated Intervention of the Healthcare Facilities Pharmacist and the Dispensary Pharmacist on the Care Pathway for Cancer Patients Treated With Oral Therapy (IPPACTTO)

Relapsed Hematologic Malignancy | Advanced or Metastatic Solid Tumor

France
Institut Cancerologie de l'Ouest

Recruiting

Multicentre Medical-economic Study Evaluating the Efficacy of Adding ZOlédronique Acid to STERéotaxique Radiotherapy in the Treatment of Vertebral Metastases (ZOSTER)

Vertebral Metastasis

France
Institut Cancerologie de l'Ouest

Recruiting

Women at Risk of Breast Cancer and OLFM4

Hereditary Breast and Ovarian Cancer Syndrome

France
Institut Cancerologie de l'Ouest

Active, not recruiting

Delayed Breast Reconstruction by Prepectoral Implant After Lipo-preparation (RM2prepec) (RM2prepec)

Breast Cancer Female

France
Institut Cancerologie de l'Ouest

Active, not recruiting

Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer (TEP-FES)

Metastatic Breast Cancer

France
Institut Cancerologie de l'Ouest

Active, not recruiting

Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology (EDHITO)

Melanoma | Renal Cell Carcinoma | Head and Neck Cancer | Advanced Non-small Cell Lung Cancer | Immune Checkpoint Inhibitors | Therapeutic Patient Education | Immune-related Adverse Event

France
Institut Cancerologie de l'Ouest

Completed

Long-term Evaluation of the Quality of Life of Former Patients Treated With Orthopedic Surgery, With or Without Radiotherapy (STARTos)

Osteosarcoma in Children

France
Institut Cancerologie de l'Ouest

Terminated

Electrotherapy in the Management of Myofascial Syndrome (MODYMYO)

Breast Cancer

France
Institut Cancerologie de l'Ouest

Completed

Longitudinal Study of Behavioral Changes, Economic and Sociological After CAncer (ELCCA-II)

Melanoma | Breast Cancer

France
Institut Cancerologie de l'Ouest

Completed

Efficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic Cancer (PAMELA70)

Toxicity | Pancreatic Metastatic Cancer

France
Institut Cancerologie de l'Ouest

Completed

Sentinel Lymph Node Detection After Neoadjuvant Chemotherapy for Large Operable Breast Cancer (GANEA2)

Breast Cancer

France
Institut Cancerologie de l'Ouest

Completed

Prospective Evaluation of the Impact on Patients' Quality of Life of a 12-Week Adapted Physical Activity Program (APA) (APA)

Sports Physical Therapy

France
Institut Cancerologie de l'Ouest

Completed

Intravenous Chemotherapy and Plant-based Dietary Supplements (CIVCAP)

Breast Cancer

France
Institut Cancerologie de l'Ouest

Completed

Biological Response to Tamoxifen (TAM) in Patients With Breast Cancer Non Metastatic RH+ (TAM)

Non Metastatic Breast Cancer

France
Institut Cancerologie de l'Ouest

Completed

Satisfaction and QUality of Life After Breast REconstruction (SQUARE)

Breast Neoplasm Female | Mammaplasty

France
Institut Cancerologie de l'Ouest

Completed

Anesthesia Feasibility Study With the CONCERT-CL® Station (CONCERT)

Cancer | Surgery

France
Institut Cancerologie de l'Ouest

Completed

Retroprospective Real Life Observatory of Eribulin (ReProLine)

Metastatic Breast Cancer

France
Institut Cancerologie de l'Ouest

Terminated

Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy (BioConnect)

Cancer

France
Institut Cancerologie de l'Ouest

Completed

Impact and Evaluation of the Management of Iron Deficiency With or Without Anemia in Patients With Cancer (CAMARA)

Iron Deficiency Anemia

France
Institut Cancerologie de l'Ouest

Completed

Geriatric Determinants of General Repercussion of Radiotherapy for Patient Over 75 Years With Prostate Cancer (PROGERAD)

Prostate Cancer

France
Institut Cancerologie de l'Ouest

Completed

ZOLEDRONIC ASSOCIATED With Hight Hypofractionated Radiotherapy Dose in Bone Metastases Vertebral Prostate Adenocarcinoma (GEMO)

Prostate Adenocarcinoma

France
Institut de Cancérologie de la Loire

Terminated

Geriatric Intervention Contribution on Quality of Life of Elderly Patients With Metastatic Neoplasia (QUALI)

Elderly Patients | Systemic Treatment | Metastatic Neoplasia

France
Institut de Cancérologie de la Loire

Completed

GRAFted Patients' anxieTY Report (GRAFTY)

Autologous Transplant Indication

France
Institut de Cancérologie de la Loire

Unknown

Feasibility Assessment of a Patients Follow-up Visit Receiving Trastuzumab Subcutaneous by Advanced Practice Nurse (TIPA)

Breast Neoplasms
Institut de Cancérologie de la Loire

Completed

Representations and Prevention of Cancers in Schools (RISCOLAIRE)

Healthy
Institut de Cancérologie de la Loire

Completed

Impact of Media Images, Alcohol and Tobacco to Youth (IMAJE)

Healthy
Institut de Cancérologie de la Loire

Completed

Cancer Fatigue Education Program

Patient With Histologically Confirmed Malignancy

France
Institut Cancerologie de l'Ouest

Recruiting

Surgery and Virtual Reality: Interest of Virtual Reality in Oncology for Procedures Under Local Anesthesia in the Operating Room (BOREV)

Cancer

France
Institut Cancerologie de l'Ouest

Recruiting

Sophrology Treatment for Patients With Glial Tumours Requiring Speech Therapy (SOPHNEURO)

Glial Tumor

France
Institut Cancerologie de l'Ouest

Recruiting

Detection and Metabolic Characterization in DOPA PET/CT of Brain Metastases (DOPACER)

MRI | Brain Metastases

France
Institut Cancerologie de l'Ouest

Recruiting

Telemedicine in the Management of Pain in Patients With Advanced or Metastatic Pancreatic Cancer (PANTELO)

Pain | Adenocarcinoma | Pancreatic Cancer Metastatic

France
Institut Cancerologie de l'Ouest

Recruiting

Persistent Organic Pollutants and Breast Cancers (POPCASE) (POPCASE)

Breast Cancer

France
Institut Cancerologie de l'Ouest

Active, not recruiting

Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer (PRESAGE)

Breast Cancer

France

3

Subscribe